Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

EPA:COVH - Euronext Paris - Matif - FR0000060303 - REIT - Currency: EUR

23  -0.4 (-1.71%)

Fundamental Rating

4

COVH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. While COVH is still in line with the averages on profitability rating, there are concerns on its financial health. COVH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year COVH was profitable.
COVH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: COVH reported negative net income in multiple years.
In the past 5 years COVH always reported a positive cash flow from operatings.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

The Return On Assets of COVH (3.14%) is better than 64.29% of its industry peers.
COVH has a Return On Equity of 6.54%. This is in the better half of the industry: COVH outperforms 66.67% of its industry peers.
With a decent Return On Invested Capital value of 3.98%, COVH is doing good in the industry, outperforming 66.67% of the companies in the same industry.
COVH had an Average Return On Invested Capital over the past 3 years of 3.85%. This is in line with the industry average of 3.74%.
The 3 year average ROIC (3.85%) for COVH is below the current ROIC(3.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.14%
ROE 6.54%
ROIC 3.98%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

COVH's Profit Margin of 80.73% is amongst the best of the industry. COVH outperforms 85.71% of its industry peers.
COVH's Profit Margin has declined in the last couple of years.
COVH has a better Operating Margin (103.45%) than 97.62% of its industry peers.
COVH's Operating Margin has been stable in the last couple of years.
COVH has a Gross Margin of 13.66%. This is amonst the worse of the industry: COVH underperforms 83.33% of its industry peers.
COVH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 103.45%
PM (TTM) 80.73%
GM 13.66%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3Y-31.67%
GM growth 5Y-15.65%
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COVH is destroying value.
COVH has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, COVH has more shares outstanding
COVH has a worse debt/assets ratio than last year.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

COVH has an Altman-Z score of 1.00. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
COVH's Altman-Z score of 1.00 is in line compared to the rest of the industry. COVH outperforms 57.14% of its industry peers.
COVH has a debt to FCF ratio of 14.45. This is a negative value and a sign of low solvency as COVH would need 14.45 years to pay back of all of its debts.
COVH has a Debt to FCF ratio (14.45) which is in line with its industry peers.
COVH has a Debt/Equity ratio of 0.74. This is a neutral value indicating COVH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.74, COVH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 14.45
Altman-Z 1
ROIC/WACC0.76
WACC5.23%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

COVH has a Current Ratio of 1.06. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
COVH has a Current ratio of 1.06. This is in the better half of the industry: COVH outperforms 76.19% of its industry peers.
A Quick Ratio of 1.06 indicates that COVH should not have too much problems paying its short term obligations.
COVH has a Quick ratio of 1.06. This is in the better half of the industry: COVH outperforms 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2041.36%, which is quite impressive.
Measured over the past years, COVH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.16% on average per year.
COVH shows a small growth in Revenue. In the last year, the Revenue has grown by 3.18%.
Measured over the past years, COVH shows a small growth in Revenue. The Revenue has been growing by 2.29% on average per year.
EPS 1Y (TTM)2041.36%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%223.86%
Revenue 1Y (TTM)3.18%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%2.25%

3.2 Future

The Earnings Per Share is expected to grow by 0.90% on average over the next years.
The Revenue is expected to grow by 0.55% on average over the next years.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.13, COVH is valued correctly.
COVH's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.22, COVH is valued a bit cheaper.
A Price/Forward Earnings ratio of 13.19 indicates a correct valuation of COVH.
COVH's Price/Forward Earnings ratio is in line with the industry average.
COVH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.86.
Industry RankSector Rank
PE 15.13
Fwd PE 13.19
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

COVH's Enterprise Value to EBITDA is on the same level as the industry average.
COVH's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. COVH is more expensive than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16
EV/EBITDA 17.91
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of COVH may justify a higher PE ratio.
PEG (NY)5.02
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.41%, COVH is a good candidate for dividend investing.
COVH's Dividend Yield is a higher than the industry average which is at 7.60.
Compared to an average S&P500 Dividend Yield of 2.44, COVH pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.41%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years3
Div Non Decr Years3
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

COVH pays out 85.75% of its income as dividend. This is not a sustainable payout ratio.
DP85.75%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (5/2/2025, 7:00:00 PM)

23

-0.4 (-1.71%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-16 2025-04-16
Earnings (Next)07-21 2025-07-21
Inst Owners32.4%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.41B
Analysts82.86
Price Target18.67 (-18.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.41%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP85.75%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.13
Fwd PE 13.19
P/S 12.25
P/FCF 16
P/OCF 9.79
P/B 0.99
P/tB 1.1
EV/EBITDA 17.91
EPS(TTM)1.52
EY6.61%
EPS(NY)1.74
Fwd EY7.58%
FCF(TTM)1.44
FCFY6.25%
OCF(TTM)2.35
OCFY10.22%
SpS1.88
BVpS23.18
TBVpS20.98
PEG (NY)5.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 6.54%
ROCE 4.5%
ROIC 3.98%
ROICexc 4.22%
ROICexgc 4.46%
OM 103.45%
PM (TTM) 80.73%
GM 13.66%
FCFM 76.53%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexcg growth 3Y33.75%
ROICexcg growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3Y-31.67%
GM growth 5Y-15.65%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 14.45
Debt/EBITDA 7.34
Cap/Depr 235.3%
Cap/Sales 48.63%
Interest Coverage 4.58
Cash Conversion 100.84%
Profit Quality 94.79%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 1
F-Score6
WACC5.23%
ROIC/WACC0.76
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2041.36%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%223.86%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.18%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%2.25%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.2%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.64%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y7.43%
OCF growth 3Y30.01%
OCF growth 5Y4.76%